John Snyder & Company, Inc. Company Profile

08:02 EDT 23rd June 2018 | BioPortfolio

John Snyder has over 25 years experience in FDA-regulated industries including drugs, biologics and medical devices. He has held senior management positions at leading firms such as Merck, Novartis and Johnson & Johnson.His industry experience encompasses the medical affairs, regulatory affairs, operations and quality assurance professions. John grew up in the industry "from the bench to the boardroom." He holds a Masters Degree in Animal Pathology from the University of Rhode Island and a Masters Degree in Pharmaceutics from Temple University.


Phone: 940-433-5044

News Articles [444 Associated News Articles listed on BioPortfolio]

Weiss Asset Management LP Raised Celgene (CELG) Stake; Snyder Capital ...

Snyder Capital Management LP decreased Idex Corp. stake by 10.94% reported in 2017Q4 SEC filing. Snyder Capital Management LP sold 75,706 shares as Idex Corp. 's stock rose 7.15%.

Mutual of America Life Insurance Company Names John R. Greed Chairman of the Board

"I am leaving the Company in the very capable hands of John Greed and a leadership team that, like John, is second to none," said Read more...

BioCatalyst: Sheridan Snyder, a true serial entrepreneur

In this episode of PharmaTelevision News Review, filmed at #BIO2012 Convention in Boston, Fintan Walton talks to Sheridan G. Snyder, LLB, OBE, Chairman, President and CEO of BioCatalyst International...

Court Dismisses Andrea Tantaros Lawsuit Against Fox News And Pete Snyder

Pete Snyder, a successful entrepreneur and technology angel capital investor, was wrongfully included in the lawsuit, a point clearly shared by Judge Daniels.  In Read more...

Campbell, Snyder’s-Lance acquisition forms new snacking unit

Campbell will be combining the Pepperidge Farm and Snyder’s-Lance port

2018 World Pizza Eating Championship At John's Incredible Pizza Company

After the event, spectators can enjoy John's all-you-can-eat buffet plus a free $5FunCard for games and rides with regular admission purchase. Photos with John's Read more...

McDonald's-Aktie: Vorteile beim Momentum! - Aktienanalyse

New York - McDonald's-Aktienanalyse von Analyst John Kernan von Cowen and Company: John Kernan, Aktienanalyst von Cowen and Company, äußert laut einer aktuellen Aktienanalyse weiterhin die Erwartun....

Molina Healthcare Announces Resignation of John Molina from the Board of Directors

Molina Healthcare, Inc. (NYSE: MOH) today announced that John C. Molina has stepped down from the Molina Healthcare Board of Directors. “We are grateful for John Molina...

PubMed Articles [146 Associated PubMed Articles listed on BioPortfolio]

Characteristics of Occupational Injuries in a Pharmaceutical Company in Iran.

To prioritize occupational hazards in a Pharmaceutical Company in Iran using the analytical hierarchy process (AHP).

John L. Cameron, MD: Overview of His Career.

: Introduction to the John Cameron Festschrift.

Rethinking Reprocessing: A Response to Snyder et al.

Attachment, hope, and participation: Testing an expanded model of Snyder's hope theory for prediction of participation for individuals with spinal cord injury.

The aim of the study was to test an expanded model of Snyder's hope theory for prediction of participation for individuals with spinal cord injury (SCI). Statistical model testing focused on evaluatio...

Bacteria and fungi in day-old turkeys vary among companies, collection periods, and breeder flocks.

Microbial colonization of the intestinal tract of commercial poultry is highly variable, likely due to the fact that poults and chicks are hatched and raised without exposure to adult birds and their ...

Clinical Trials [119 Associated Clinical Trials listed on BioPortfolio]

A Placebo-Controlled Trial of St. John's Wort for Irritable Bowel Syndrome

This study is being done to see if St. John's wort helps people with irritable bowel syndrome, otherwise known as "IBS". St. John's wort is a herbal supplement derived from the St. John's ...

Pilot Pharmacokinetic Study of a Prolonged-release Formulation of St. John's Wort Extract Ze 117

A pilot phase I, randomised, open mono-center, two parallel group clinical trial investigating the pharmacokinetics of a prolonged-release formulation in comparison to an immediate-release...

St. John's Wort Versus Placebo in Social Phobia

The purpose of this study is to determine the effectiveness of St. John’s Wort as compared to placebo (an inactive substance) in the treatment of outpatients with social phobia.

Effects of St. John's Wort on the Effectiveness of Oral Contraceptives

The purpose of this study is to evaluate the effects of a common herbal remedy, St. John's Wort, on the effectiveness of birth control pills. St. John's Wort has recently been shown to inc...

St. John's Wort in Relieving Fatigue in Patients Undergoing Chemotherapy or Hormone Therapy for Cancer

RATIONALE: Giving St. John's wort may be effective in relieving fatigue in patients with cancer who are undergoing chemotherapy or hormone therapy. PURPOSE: Randomized phase III trial to ...

Companies [1629 Associated Companies listed on BioPortfolio]

John Snyder & Company, Inc.

John Snyder has over 25 years experience in FDA-regulated industries including drugs, biologics and medical devices. He has held senior management positions at leading firms such as Merck, Novartis a...

John Hancock Financial

John Hancock Financial is a unit of Manulife Financial Corporation (the Company), a leading Canadian-based financial services group serving millions of customers in 19 countries and territories worldw...

John Muir Medical Center

John Muir Health was formed in 1997 when John Muir Medical Center in Walnut Creek merged with John Muir Medical Center, Concord Campus in Concord. Creation of John Muir Health ensures that comprehensi...

Long John Silver’s

Long John Silver’s, America’s largest quick service seafood chain, was founded in Lexington, KY, in 1969 and moved its international headquarters to Louisville in 2003. ...

John L. Scott Real Estate

John L. Scott Real Estate was founded in 1931 and is currently led by third generation chairman and CEO, J. Lennox Scott. With over 61,000 closed transactions last year, John L. Scott grossed more tha...

More Information about "John Snyder & Company, Inc." on BioPortfolio

We have published hundreds of John Snyder & Company, Inc. news stories on BioPortfolio along with dozens of John Snyder & Company, Inc. Clinical Trials and PubMed Articles about John Snyder & Company, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of John Snyder & Company, Inc. Companies in our database. You can also find out about relevant John Snyder & Company, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topic

The Top 100 Pharmaceutical Companies
Top 10 biotech and pharmaceutical companies worldwide based on market value in 2015 2015 ranking of the global top 10 biotech and pharmaceutical companies based on revenue (in billion U.S. dollars) Johnson & Johnson, U.S. 74...

Corporate Database Quicklinks

Searches Linking to this Company Record